Anne Aupérin

机构：Inserm, Université Paris-Saclay, Institut Gustave Roussy, La Ligue Contre le Cancer · ORCID：0000-0003-1545-0373

发表论文 55 篇 · 总被引 2197 次 · h-index 9

代表论文

• NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse. (2025 · Journal of Clinical Oncology · 被引 58)
• Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma (2024 · CPT Pharmacometrics & Systems Pharmacology · 被引 4)
• Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial (2026 · The Lancet Healthy Longevity · 被引 3)
• Digital Pathology in Real-Life Conditions for Daily Cytopathological Diagnosis: A Feasibility Study (2025 · Acta Cytologica · 被引 2)
• CHEMOTHERAPY-ONLY TREATMENT IN LOW AND STANDARD RISK MATURE B-CELL NON-HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS: POOLED ANALYSIS OF THE FAB/LMB96 AND LMB2001 STUDIES (2025 · Leukemia Research · 被引 1)
• Hypofractionated Split-Course Versus Standard Radiotherapy in Frail Elderly Patients with Head and Neck Squamous-Cell Carcinoma (ELAN-RT): A Multicenter, Open-Label, Randomized, Non-Inferiority GORTEC Trial (2025 · SSRN Electronic Journal · 被引 1)